The Johnson & Johnson talcum powder mass tort spans two related but distinct injury categories. Ovarian cancer claims allege that long-term genital application of talc-based powder products causes ovarian cancer through inflammation and other mechanisms. Mesothelioma claims allege that asbestos contamination of J&J's talc supply caused mesothelioma in users and workers exposed to the products.
J&J has discontinued global sale of talc-based Baby Powder (transitioning to cornstarch-based formulations) but continues to face substantial litigation. The company has attempted multiple settlement strategies through its Red River Talc / LTL Management subsidiary, including bankruptcy-based settlement frameworks that have been challenged in federal court.
Year-round qualification continues across multiple parallel proceedings (state-court litigation, federal MDL, bankruptcy court). Highfloor supports per-firm talcum powder flights with bar TV reaching the affected demographic plus broadcast TV reaching the family-decision-maker audience.
- Year-round flights — long-running active docket
- Bar TV in metros with broad demographic reach
- Broadcast TV during daytime windows reaching the family-decision-maker demographic
- Search-keyword spend on talcum-powder-cancer-specific terms
- Targeted programmatic display
- 1999 — first ovarian cancer talcum powder lawsuit
- 2016–2018 — major bellwether verdicts (Hogans, Lanzo, multiple others)
- 2020 — J&J discontinues talc-based Baby Powder in U.S.
- 2021–2025 — Red River Talc / LTL Management bankruptcy strategies and federal-court challenges
- Ongoing — substantial ongoing qualification across multiple proceedings
- Distributed across major metros — broad demographic eligibility
- Particular concentration in Chicago, Atlanta, NYC for both injury categories